-
Event
20 November 2026, The Hotel Brussels & Online
Advancing Collaboration, Skills and Person-Centred Care through INTERACT-EUROPE 100
Bringing together Europe’s oncology community at a pivotal moment, this conference will showcase the achievements of INTERACT-EUROPE 100 while charting the next phase of inter-speciality cancer training across Europe. It offers a unique opportunity to transform the programme’s success into lasting, system-wide adoption, ultimately advancing cancer care and outcomes for people across Europe.
Read more
-
Event
20 November 2026, The Hotel Brussels
Quality of life is a key priority for anyone affected by cancer, but it remains insufficiently addressed in cancer research, care and policy.
On 20 November, the Quality of Life and Cancer Policy Forum will explore lessons from nine innovative projects and how cancer systems can be redesigned towards patient-centred care.
Taking place a day after the European Cancer Summit 2026 – and at the same venue – this high-level, implementation-focused event will bring together patient representatives, researchers, healthcare professionals, health system managers and policymakers to learn about the latest EU-supported initiatives and get empowered to drive meaningful change.
This event will feature:
- the EUonQoL project, developing a patient-centred unified tool for the assessment of quality of life among cancer patients and survivors – serving as its final policy event
- the projects of the Quality of Life - Patient-Centred Care Cluster of the EU Mission on Cancer – serving as their multi-stakeholder meeting
Read more
-
Event
18 - 19 November 2026, Brussels & online
Strengthening Cancer Care: Securing a Healthy, Equitable, Resilient and Competitive Europe
Amid political instability, economic pressure, and the risk of escalating conflict, discussions around Europe’s next multiannual budget are intensifying in Brussels and in capitals across the EU.
In this environment, addressing the growing burden of cancer is essential. This unrelenting disease is not only a public health priority, but a strategic investment in Europe’s resilience, social cohesion and long‑term competitiveness.
As Europe defines its political priorities for the decade ahead, health and cancer must be embedded at the heart of future investments. At this critical moment, the cancer community must champion a vision for a resilient, equitable and innovative Europe.
The European Cancer Summit 2026 will take place in Brussels & online on 18-19 November, followed by EU-funded project events on 20 November.
Read more
-
Event
29 October 2026, Online
People living with and beyond cancer often say that quality of life matters as much as clinical outcomes. Yet quality of life is still not measured consistently and their experience is frequently not reflected in healthcare planning or policy decisions.
On 29 October, the EUonQoL project will bring together patients, caregivers, healthcare professionals, policymakers and others to explore how quality-of-life measurement can become a stronger part of cancer care and decision-making across Europe.
The event will also launch the EUonQoL Policy Recommendations, setting out concrete actions to strengthen the use of harmonised, patient-reported data.
Read more
-
Event
13 - 14 October 2026, The Hoxton
The SANGUINE Project Showcase Event:
Advancing the HemaChip from Research to Impact
Every year, around 300,000 people across the EU are diagnosed with a haematological malignancy, including leukaemia, lymphoma and multiple myeloma.
Yet diagnosing blood cancer remains a complex challenge. With more than 100 different types and subtypes, many diseases share overlapping clinical and laboratory features, requiring multiple tests to reach an accurate diagnosis.
Read more
-
community-voices
September 2026
By Billy Kelleher, MEP
Ireland's presidency of the Council of the European Union started this month, and it comes at a serious moment for Europe – and for Ireland.
For six months, we will help steer the Council's work: chairing meetings, brokering agreement among Member States, and working with the Parliament and Commission to find solutions to the many challenges now before us.
Read more
-
community-voices
September 2026
By Anna R. Giuliano, PhD, President, International Papillomavirus Society
For five straight years, not one young woman in England died of cervical cancer.
Between 2020 and 2024, deaths in women aged 20 to 24 fell to zero – a first. That’s because each had been given a vaccine at 12 or 13 years of age, a vaccine many people today still do not realise prevents cervical cancer.
Read more
-
news
06 August 2026
The European Cancer Organisation (ECO) has submitted its response to the European Commission’s public consultation on the proposed EU Biotech Act, welcoming its potential to strengthen European innovation and access for patients, while proposing needed additional measures.
The Biotech Act represents an important opportunity to create a European environment in which biotechnology research and innovation can flourish. For cancer care, this could accelerate progress in areas including advanced therapies, precision medicine, radiopharmaceuticals, and AI-enabled diagnostics, helping innovative treatments reach patients more quickly and equitably.
Following the publication of the European Biotech Act proposal on 16 December 2025, the European Commission invited stakeholders to provide feedback.
ECO’s response focuses on three priorities: improving the regulatory environment for clinical trials in Europe; strengthening access to Advanced Therapy Medicinal Products (ATMPs); and ensuring greater policy attention is given to health and oncology workforce needs.
Read more
-
Publication
August 2026
The report is the latest output from the EU-CIP (European Cancer Information Portal) project. It is entitled Building a Trusted and Accessible Cancer Information Ecosystem in Europe and brings together the findings of the April 2026 EU-CIP Stakeholder Co-Creation Forum, organised by the European Cancer Organisation with the support of project partners.
Read more
